Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan

OBJECTIVE: The purpose of this analysis was to evaluate the cost effectiveness of the combination of pertuzumab, trastuzumab, and docetaxel (PTD) for the treatment of patients with human epidermal growth factor receptor-2 (HER2)-positive breast cancer in Japan. METHODS: A partitioned survival analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriwaki, Kensuke, Uechi, Saki, Fujiwara, Takaaki, Hagino, Yu, Shimozuma, Kojiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333148/
https://www.ncbi.nlm.nih.gov/pubmed/33483889
http://dx.doi.org/10.1007/s41669-020-00254-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333148/
https://www.ncbi.nlm.nih.gov/pubmed/33483889
http://dx.doi.org/10.1007/s41669-020-00254-3

Ejemplares similares